This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 1488
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
==Enterococcus faecalis Penicillin Binding Protein 4 (PBP4)== | ==Enterococcus faecalis Penicillin Binding Protein 4 (PBP4)== | ||
<StructureSection load='6bsq' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='6bsq' size='340' side='right' caption='Caption for this structure' scene=''> | ||
| - | + | Penicillin-binding proteins (PBPs) have been scrutinized for over 40 years. Recent structural information on PBPs together with the ongoing long-term biochemical experimental investigations, and results from more recent techniques such as protein localization by green fluorescent protein-fusion immunofluorescence or double-hybrid assay, have brought our understanding of the last stages of the peptidoglycan biosynthesis to an outstanding level that allows a broad outlook on the properties of these enzymes. Details are emerging regarding the interaction between the peptidoglycan-synthesizing PBPs and the peptidoglycan, their mesh net-like product that surrounds and protects bacteria<ref>DOI:10.1111/j.1574-6976.2008.00105.x</ref>. | |
| - | + | ||
==Function == | ==Function == | ||
| Line 10: | Line 10: | ||
PBPs are classified by their enzymatic activity: | PBPs are classified by their enzymatic activity: | ||
(1) class A, bifunctional PBPs with both glycosyltransferase and transpeptidase activities; | (1) class A, bifunctional PBPs with both glycosyltransferase and transpeptidase activities; | ||
| + | |||
(2) class B, transpeptidases; and | (2) class B, transpeptidases; and | ||
| + | |||
(3) class C, carboxy-peptidases and endopeptidases. | (3) class C, carboxy-peptidases and endopeptidases. | ||
| - | |||
| - | |||
== Disease == | == Disease == | ||
| + | Enterococci exhibits tolerance to the bactericidal activity of β-lactams <ref>DOI:10.1172/JCI106758</ref> , a phenomenon that compromises the use of β-lactam antibiotics as single agents in the treatment of enterococcal endocarditis <ref>DOI: 10.1056/NEJM196603312741304</ref>. As a consequence, multi-resistant E. faecium and E. faecalis represent one of the most dangerous threats in infectious diseases therapeutics. | ||
| + | |||
| + | Rare strains of E. faecalis and most nosocomial strains of E. faecium exhibit even higher levels of resistance to penicillins, effectively eliminating β-lactams as a treatment option <ref>doi: 10.1086/533452</ref>. Of greater concern is the observation that prolonged β-lactam therapy can lead to the emergence of highly resistant strains. | ||
== Structure == | == Structure == | ||
Revision as of 13:30, 10 January 2019
| This Sandbox is Reserved from 06/12/2018, through 30/06/2019 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1480 through Sandbox Reserved 1543. |
To get started:
More help: Help:Editing |
Enterococcus faecalis Penicillin Binding Protein 4 (PBP4)
| |||||||||||
References
- ↑ Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev. 2008 Mar;32(2):234-58. doi: 10.1111/j.1574-6976.2008.00105.x., Epub 2008 Feb 11. PMID:18266856 doi:http://dx.doi.org/10.1111/j.1574-6976.2008.00105.x
- ↑ Moellering RC Jr, Weinberg AN. Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. J Clin Invest. 1971 Dec;50(12):2580-4. doi: 10.1172/JCI106758. PMID:5001959 doi:http://dx.doi.org/10.1172/JCI106758
- ↑ Jawetz E, Sonne M. Penicillin-streptomycin treatment of enterococcal endocarditis. A re-evaluation. N Engl J Med. 1966 Mar 31;274(13):710-5. doi: 10.1056/NEJM196603312741304. PMID:5908873 doi:http://dx.doi.org/10.1056/NEJM196603312741304
- ↑ Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008 Apr 15;197(8):1079-81. doi: 10.1086/533452. PMID:18419525 doi:http://dx.doi.org/10.1086/533452
